Paras Healthcare Reports ₹40 Crore Q2 Net Profit in Its First Earnings Update Post-Listing

Paras Healthcare reported a substantial increase in profit for the September quarter, achieving a profit after tax of Rs 40.35 crore, compared to Rs 12.38 crore in the same period last year. This notable growth can be attributed to a rise in revenue, which reached Rs 510.89 crore during the second quarter of FY27. The company’s expenses for this period were Rs 463.12 crore, reflecting strategic cost management, and underscoring their effective operational execution in a competitive market post-IPO.

The successful IPO concluded on October 23, with shares debuting on the BSE and NSE shortly thereafter. The company raised Rs 500 crore, utilizing Rs 375 crore for debt repayment. This strategic move has notably strengthened Paras Healthcare’s balance sheet, positioning the company for future growth initiatives in specialty programs, including oncology and cardiac care, as highlighted by Managing Director Dharminder Kumar Nagar. The focus on underserved markets in North India indicates a calculated expansion strategy aligned with current healthcare demands.

Shares of Paras Healthcare saw a positive trajectory, closing 2.99 percent higher at Rs 774.35 each. This upward movement reflects market confidence in the company’s growth prospects and operational strategy. As the company aims to enhance its clinical offerings and invest in advanced technology, it is poised to capitalize on emerging healthcare trends and patient needs in the region.

Source: The Economic Times

(Expert Note: This intelligence brief was structured and verified by the Wealthova editorial desk.)